1. Home
  2. FNV vs ALC Comparison

FNV vs ALC Comparison

Compare FNV & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNV
  • ALC
  • Stock Information
  • Founded
  • FNV 1986
  • ALC 1945
  • Country
  • FNV Canada
  • ALC Switzerland
  • Employees
  • FNV N/A
  • ALC N/A
  • Industry
  • FNV Precious Metals
  • ALC Ophthalmic Goods
  • Sector
  • FNV Basic Materials
  • ALC Health Care
  • Exchange
  • FNV Nasdaq
  • ALC Nasdaq
  • Market Cap
  • FNV 35.5B
  • ALC 40.2B
  • IPO Year
  • FNV 2007
  • ALC N/A
  • Fundamental
  • Price
  • FNV $200.85
  • ALC $77.20
  • Analyst Decision
  • FNV Buy
  • ALC Buy
  • Analyst Count
  • FNV 8
  • ALC 10
  • Target Price
  • FNV $178.75
  • ALC $96.73
  • AVG Volume (30 Days)
  • FNV 684.5K
  • ALC 2.4M
  • Earning Date
  • FNV 11-05-2025
  • ALC 11-11-2025
  • Dividend Yield
  • FNV 0.75%
  • ALC 0.28%
  • EPS Growth
  • FNV N/A
  • ALC N/A
  • EPS
  • FNV 4.08
  • ALC 2.16
  • Revenue
  • FNV $1,321,000,000.00
  • ALC $10,025,000,000.00
  • Revenue This Year
  • FNV $50.06
  • ALC $5.95
  • Revenue Next Year
  • FNV $12.39
  • ALC $7.56
  • P/E Ratio
  • FNV $49.35
  • ALC $35.85
  • Revenue Growth
  • FNV 17.56
  • ALC 4.04
  • 52 Week Low
  • FNV $112.70
  • ALC $77.12
  • 52 Week High
  • FNV $204.92
  • ALC $100.71
  • Technical
  • Relative Strength Index (RSI)
  • FNV 70.76
  • ALC 36.98
  • Support Level
  • FNV $198.63
  • ALC $77.36
  • Resistance Level
  • FNV $204.92
  • ALC $80.91
  • Average True Range (ATR)
  • FNV 4.16
  • ALC 1.22
  • MACD
  • FNV 0.32
  • ALC -0.00
  • Stochastic Oscillator
  • FNV 80.98
  • ALC 3.13

About FNV Franco-Nevada Corporation

Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. Franco-Nevada's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project, located in the U.S, Canada, and Australia.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: